These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 8396059)

  • 1. Pharmacological action of (-)-(2S,3aR,7aS)-1-[(S)-N-[(S)-1-carbonyl-3- phenylpropyl]alanyl]hexahydro-2-indolinecarboxylic acid (trandolaprilat) in isolated smooth muscle preparations.
    Sekiguchi N; Ishii Y; Fujikura H; Hasegawa Y; Takayanagi I
    Gen Pharmacol; 1993 May; 24(3):585-90. PubMed ID: 8396059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The endothelium and vascular effects of the ACE inhibitor trandolaprilat.
    Vidal M; Joly G; Mombouli JV; Boulanger CM; Vanhoutte PM
    J Cardiovasc Pharmacol; 1994; 23 Suppl 4():S1-5. PubMed ID: 7527094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potentiation by trandolaprilat of the endothelium-dependent hyperpolarization induced by bradykinin.
    Illiano S; Mombouli JV; Nagao T; Vanhoutte PM
    J Cardiovasc Pharmacol; 1994; 23 Suppl 4():S6-10. PubMed ID: 7527103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the new angiotensin-I-converting enzyme inhibitor imidapril on the responses of isolated vascular preparations to various agonists.
    Kubo M; Fujitsuka T; Ishida R
    Arzneimittelforschung; 1992 Apr; 42(4):446-51. PubMed ID: 1642667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potentiation of bradykinin effects and inhibition of kininase activity in isolated smooth muscle.
    Schaffel R; Rodrigues MS; Assreuy J
    Can J Physiol Pharmacol; 1991 Jul; 69(7):904-8. PubMed ID: 1659490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelium-dependent effect of perindopril and enalaprilat in rat thoracic aorta.
    Fang ZY; Li YF; Zhang LL; Liu DJ; Li YQ
    Zhongguo Yao Li Xue Bao; 1996 Nov; 17(6):519-23. PubMed ID: 9863146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different effects of angiotensin-converting enzyme inhibition in human arteries and veins.
    Yang Z; Arnet U; von Segesser L; Siebenmann R; Turina M; Lüscher TF
    J Cardiovasc Pharmacol; 1993; 22 Suppl 5():S17-22. PubMed ID: 7508047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Previous exposure to bradykinin unmasks an endothelium-dependent relaxation to the converting enzyme inhibitor trandolaprilat in isolated canine coronary arteries.
    Desta B; Nakashima M; Kirchengast M; Vanhoutte PM; Boulanger CM
    J Pharmacol Exp Ther; 1995 Feb; 272(2):885-91. PubMed ID: 7531766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelium-dependent relaxation by angiotensin-converting enzyme inhibitors in canine femoral arteries.
    Moroi M; Akatsuka N; Fukazawa M; Hara K; Ishikawa M; Aikawa J; Namiki A; Yamaguchi T
    Am J Physiol; 1994 Feb; 266(2 Pt 2):H583-9. PubMed ID: 8141360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nitric oxide pathway-mediated relaxant effect of bradykinin in the guinea-pig isolated trachea.
    Schlemper V; Calixto JB
    Br J Pharmacol; 1994 Jan; 111(1):83-8. PubMed ID: 8012728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological properties of the new non-sulfhydryl angiotensin converting enzyme inhibitor N-[8-amino-1(S)-carboxyoctyl]-L-alanyl-L-proline.
    Shirota M; Kajiwara Y; Iijima M; Kitabatake K
    Arzneimittelforschung; 1990 May; 40(5):515-9. PubMed ID: 2166521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the effects of two new arginine/citrulline analogues on constitutive and inducible nitric oxide synthases in rat aorta.
    Joly GA; Narayanan K; Griffith OW; Kilbourn RG
    Br J Pharmacol; 1995 Jun; 115(3):491-7. PubMed ID: 7582462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of angiotensin converting enzyme by CV-3317, a non-sulfhydryl compound.
    Inada Y; Terashita Z; Imura Y; Tanabe M; Nishikawa K; Kikuchi S
    Jpn J Pharmacol; 1986 Sep; 42(1):99-108. PubMed ID: 3025487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Demonstration of extrapulmonary activity of angiotensin converting enzyme in intact tissue preparations.
    Lembeck F; Griesbacher T; Eckhardt M
    Br J Pharmacol; 1990 May; 100(1):49-54. PubMed ID: 2164861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelial factors involved in the bradykinin-induced relaxation of the guinea-pig aorta.
    Kamei M; Yoneda Y; Suzuki H
    J Smooth Muscle Res; 2000 Aug; 36(4):127-35. PubMed ID: 11286296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biphasic response to bradykinin in isolated porcine iliac arteries is mediated by bradykinin B1 and B2 receptors.
    Persson K; Andersson RG
    J Cardiovasc Pharmacol; 1998 Feb; 31(2):306-13. PubMed ID: 9475274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactions of nitric oxide synthase inhibitors and dexamethasone with alpha-adrenoceptor-mediated responses in rat aorta.
    Adeagbo AS; Triggle CR
    Br J Pharmacol; 1993 Jun; 109(2):495-501. PubMed ID: 7689395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selectivity of converting-enzyme inhibitors for angiotensin I versus bradykinin hydrolysis reactions.
    Brooks RR; Miller KE; Jones SM; Burns RH; Huang CT
    J Pharm Sci; 1990 May; 79(5):384-8. PubMed ID: 2161922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Inhibitory effect of N-alpha-[(S)-1-carboxy-3-phenylpropyl]-L-lysyl-L-proline (MK-0521) on angiotensin converting enzyme in vitro].
    Ino Y; Oda M; Sato T; Iwaki M
    Nihon Yakurigaku Zasshi; 1989 Apr; 93(4):219-24. PubMed ID: 2545578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative study on the mechanism of bradykinin potentiation induced by bradykinin-potentiating peptide 9a, enalaprilat and kinin-potentiating peptide.
    Rodrigues MS; Schaffel R; Assreuy J
    Eur J Pharmacol; 1992 Jun; 216(3):357-62. PubMed ID: 1330581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.